About
Bioanalytical Services
Areas of Focus
Categories
Contract ResearchContract ResearchContract ResearchServices
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
301
By Phase
PHASE3: 3PHASE1: 2PHASE4: 2
By Status
COMPLETED: 5UNKNOWN: 2
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05843916Lead Sponsor
Switch Over Study of Biosimilar AGA for Fabry Disease
PHASE3Unknown
20 participants
Started: Dec 13, 2022 · Completed: Dec 1, 2023
NCT05343715Lead Sponsor
PK/PD Study of 2 Agalsidase Formulations in Single Dose of 1 mg/kg Administered to Healthy Volunteers as IV Infusion
PHASE1Completed
24 participants
Started: Oct 23, 2021 · Completed: Apr 17, 2022
NCT04036253Lead Sponsor
Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease
PHASE3Completed
43 participants
Started: Feb 28, 2018 · Completed: Aug 31, 2021
NCT03822884Lead Sponsor
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
PHASE1Completed
24 participants
Started: Sep 30, 2016 · Completed: Dec 31, 2016
NCT01945788Lead Sponsor
Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo
PHASE4Unknown
110 participants
Started: Jun 30, 2013 · Completed: Nov 30, 2014
Locations (1)
Headquarters
Bielefeld, Germany
Map
Loading map...